• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by iTonic Holdings Ltd

    4/23/26 4:15:02 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $ITOC alert in real time by email
    6-K 1 ea0287472-6k_itonic.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of April, 2026

     

    Commission File Number: 001-42263

     

    iTonic Holdings Ltd

     

    Room 306, NET Building

    Hong Jun Ying South Road, Chaoyang District

    Beijing, China 

     

    Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

     

    Form 20-F ☒       Form 40-F ☐

     

     

     

     

     

    Exhibits

     

    Exhibit No.   Description
    99.1   Press Release

     

    1

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      iTonic Holdings Ltd
         
    Date: April 23, 2026 By: /s/ Jianfei Zhang
      Name:  Jianfei Zhang
      Title: Chief Executive Officer and Chairman of the Board of Directors

     

    2

     

    Get the next $ITOC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ITOC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ITOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Zhang Jianfei

    3 - iTonic Holdings Ltd (0001970544) (Issuer)

    4/7/26 8:11:38 AM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Zhang Pengfei

    3 - iTonic Holdings Ltd (0001970544) (Issuer)

    3/16/26 9:50:43 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Li Zhixin

    3 - iTonic Holdings Ltd (0001970544) (Issuer)

    3/16/26 4:54:48 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule

    BEIJING, China, April 23, 2026 (GLOBE NEWSWIRE) -- iTonic Holdings Ltd (the "Company" or "ITOC"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced that on April 21, 2026, it received notification from The Nasdaq Stock Market LLC ("Nasdaq") that Nasdaq approved the Company's request for an extension of additional 180-calendar day, or until October 19, 2026 (the "Extension") to regain compliance with the minimum closing bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Rule").The Extension follows the expiration the initial 180-calendar day compliance p

    4/23/26 4:05:00 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ITOC
    SEC Filings

    View All

    SEC Form 6-K filed by iTonic Holdings Ltd

    6-K - iTonic Holdings Ltd (0001970544) (Filer)

    4/23/26 4:15:02 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form 20-F/A filed by iTonic Holdings Ltd

    20-F/A - iTonic Holdings Ltd (0001970544) (Filer)

    4/2/26 4:16:17 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 20-F filed by iTonic Holdings Ltd

    20-F - iTonic Holdings Ltd (0001970544) (Filer)

    3/30/26 5:31:10 PM ET
    $ITOC
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care